Literature DB >> 6652344

Glucocorticoid protection against PAF-acether toxicity in mice.

A Myers, E Ramey, P Ramwell.   

Abstract

Intravenous platelet activating factor (PAF-acether, 10 to 25 micrograms/kg body weight) produced dose-dependent mortality in both male and female mice. Pretreatment with indomethacin (50 mg/kg), verapamil (40 mg/kg) or nifedipine (4 mg/kg) failed to inhibit the lethal effect of 20 micrograms/kg PAF-acether. This suggests that neither arachidonate cyclo-oxygenase products nor availability of extracellular Ca2+ mediate the toxic action. In contrast, pretreatment with 100 mg/kg cortisone acetate (s.c.) daily for four days exerted a highly protective effect, i.e. 100% and 93% survival in males and females, compared to 13% and 7% respectively, in untreated animals. PAF-acether-induced death may be a useful model for the in vivo evaluation of pharmacological agents in anaphylactic shock.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6652344      PMCID: PMC2044884          DOI: 10.1111/j.1476-5381.1983.tb11034.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  Intravenous arachidonate in the mouse: a model for the evaluation of antithrombotic drugs.

Authors:  C Kohler; W Wooding; L Ellenbogen
Journal:  Thromb Res       Date:  1976-07       Impact factor: 3.944

2.  Intravascular aggregation and pulmonary sequestration of platelets during IgE-induced systemic anaphylaxis in the rabbit: abrogation of lethal anaphylactic shock by platelet depletion.

Authors:  R N Pinckard; M Halonen; J D Palmer; C Butler; J O Shaw; P M Henson
Journal:  J Immunol       Date:  1977-12       Impact factor: 5.422

3.  Antihypertensive activity of an alkyl ether analog of phosphatidylcholine.

Authors:  M L Blank; F Snyder; L W Byers; B Brooks; E E Muirhead
Journal:  Biochem Biophys Res Commun       Date:  1979-10-29       Impact factor: 3.575

4.  Endogenous inhibitors of lipoxygenase.

Authors:  S A Saeed; M Drew; H O Collier
Journal:  Eur J Pharmacol       Date:  1980-10-03       Impact factor: 4.432

5.  Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives.

Authors:  B B Vargaftig; J Lefort; M Chignard; J Benveniste
Journal:  Eur J Pharmacol       Date:  1980-07-25       Impact factor: 4.432

6.  Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit.

Authors:  L M McManus; D J Hanahan; C A Demopoulos; R N Pinckard
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

7.  [Platelet aggregation and platelet activating factor (author's transl)].

Authors:  M Chignard; B B Vargaftig; J Benveniste; J P Le Couedic
Journal:  J Pharmacol       Date:  1980 Oct-Dec

8.  Effect of corticosteroids on arachidonate induced mortality in male and female mice.

Authors:  J C Penhos; M Montalbert-Smith; F Rabbani; E Ramey; P W Ramwell
Journal:  Prostaglandins       Date:  1979-11

9.  Endogenous inhibitor of prostaglandin synthetase.

Authors:  S A Saeed; W J McDonald-Gibson; J Cuthbert; J L Copas; C Schneider; P J Gardiner; N M Butt; H O Collier
Journal:  Nature       Date:  1977-11-03       Impact factor: 49.962

10.  Pathophysiological states modify levels in rat plasma of factors which inhibit synthesis and enhance breakdown of PG.

Authors:  P K Moore; J R Hoult
Journal:  Nature       Date:  1980-11-20       Impact factor: 49.962

View more
  15 in total

1.  Induction of platelet-activating factor in mice by intravenous administration of a neutral fraction of bakers' yeast mannan.

Authors:  T Mikami; K Fukushi; M Ishitani; K Ishitani; S Suzuki; M Suzuki
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

Review 2.  Mast cell modulation of the vascular and lymphatic endothelium.

Authors:  Christian A Kunder; Ashley L St John; Soman N Abraham
Journal:  Blood       Date:  2011-09-08       Impact factor: 22.113

3.  Effects of inhibitors of arachidonic acid metabolism on Paf-induced gastric mucosal necrosis and haemoconcentration.

Authors:  J L Wallace; B J Whittle
Journal:  Br J Pharmacol       Date:  1986-10       Impact factor: 8.739

4.  Relationships between tumour necrosis factor, eicosanoids and platelet-activating factor as mediators of endotoxin-induced shock in mice.

Authors:  A K Myers; J W Robey; R M Price
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

5.  Platelet-activating factor receptor mRNA is localized in eosinophils and epithelial cells in rat small intestine: regulation by dexamethasone and gut flora.

Authors:  H Wang; X Tan; H Chang; W Huang; F Gonzalez-Crussi; W Hsueh
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

6.  Altered inflammatory responses in leukotriene-deficient mice.

Authors:  J L Goulet; J N Snouwaert; A M Latour; T M Coffman; B H Koller
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

7.  Paf-acether-induced death in mice: involvement of arachidonate metabolites and beta-adrenoceptors.

Authors:  M Criscuoli; A Subissi
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

8.  Inhaled budesonide fails to inhibit the PAF-induced increase in plasma leukotriene B4 in man.

Authors:  M M Nieminen; E K Moilanen; M O Koskinen; J I Karvonen; L Tuomisto; T J Metsä-Ketelä; H Vapaatalo
Journal:  Br J Clin Pharmacol       Date:  1992-06       Impact factor: 4.335

9.  In vivo responses of mouse blood cells to platelet-activating factor (PAF): role of the mediators of anaphylaxis.

Authors:  D Kelefiotis; C Vakirtzi-Lemonias
Journal:  Agents Actions       Date:  1993-11

10.  Body temperature modulates the effect of platelet-activating factor (PAF) on airways responsiveness in the rabbit.

Authors:  M M Nieminen; M Hill; C G Irvin
Journal:  Agents Actions       Date:  1991-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.